Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Aug 2026 for Caris Life Sciences, Inc.. Read the official filing
Filing timeline
BuySaleJon Halbert
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jon Halbert: trading record in brief
All filings by Jon Halbert on record concern Caris Life Sciences, Inc. The record holds 4 filings, for trades running from 27 February 2025 to 14 August 2026.
Every open-market trade on record is a purchase: 1 purchase worth €851k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 3 share grants. Since January 2026: 1 purchase and no sales on the market.
The latest filing, published on 14 August 2026, reports a share grant in Caris Life Sciences, Inc. The clock since the last published purchase (13 July 2026) now reads 97 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 59 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jon Halbert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
13,192 shares0Common StockSEC:0001189394-26-000008:0
68,000 shares@ US$14.560.049% mcap95.3% of flowCommon StockSEC:0001189394-26-000005:0
Canonical exit: 13 Aug 2026 (T+90)
2,492 shares@ US$20.06100.0% of flowCommon StockSEC:0001189394-26-000002:0
16,129 shares0Common StockSEC:0001104659-25-061813:0
4 of 4 declarations
